Polyglutamine Binding Peptide 1 (QBP1) inhibits polyglutamine aggregation and cytotoxicity in vitro and in an in vivo disease model.

被引：0
|
作者：
Nagai, Y
Ren, H
Burke, JR
Strittmatter, WJ
Fujikake, N
Higashiyama, H
Yamaguchi, M
Toda, T
机构：
[1] Osaka Univ, Grad Sch Med, Dept Post Genom & Dis, Div Funct Genom, Suita, Osaka, Japan
[2] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
[3] Osaka Biosci Inst, Dept Mol Med Sci, Suita, Osaka 565, Japan
[4] Aichi Canc Ctr, Res Inst, Cell Biol Sect, Div Biochem, Nagoya, Aichi 464, Japan
来源：
AMERICAN JOURNAL OF HUMAN GENETICS | 2001年 / 69卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
179
引用
收藏
页码：211 / 211
页数：1
相关论文
共 50 条
  • [1] Polyglutamine Binding Peptide 1 (QBP1) inhibits polyglutamine aggregation and rescues neurological phenotypes in Drosophila polyglutarnine disease models.
    Nagal, Y
    Fujikake, N
    Ohno, K
    Higashiyama, H
    Inui, T
    Popiel, HA
    Urade, Y
    Yamaguchi, M
    Strittmatter, WJ
    Burke, JR
    Toda, T
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 470 - 470
  • [2] Inhibition of Protein Misfolding/Aggregation Using Polyglutamine Binding Peptide QBP1 as a Therapy for the Polyglutamine Diseases
    H. Akiko Popiel
    Toshihide Takeuchi
    James R. Burke
    Warren J. Strittmatter
    Tatsushi Toda
    Keiji Wada
    Yoshitaka Nagai
    Neurotherapeutics, 2013, 10 : 440 - 446
  • [3] Inhibition of Protein Misfolding/Aggregation Using Polyglutamine Binding Peptide QBP1 as a Therapy for the Polyglutamine Diseases
    Popiel, H. Akiko
    Takeuchi, Toshihide
    Burke, James R.
    Strittmatter, Warren J.
    Toda, Tatsushi
    Wada, Keiji
    Nagai, Yoshitaka
    NEUROTHERAPEUTICS, 2013, 10 (03) : 440 - 446
  • [4] Structure-activity relationship study on polyglutamine binding peptide QBP1
    Tomita, Kenji
    Popiel, H. Akiko
    Nagai, Yoshitaka
    Toda, Tatsushi
    Yoshimitsu, Yuji
    Ohno, Hiroaki
    Oishi, Shinya
    Fujii, Nobutaka
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (03) : 1259 - 1263
  • [5] The β-turn-supporting motif in the polyglutamine binding peptide QBP1 is essential for inhibiting huntingtin aggregation
    Belwal, Vinay Kumar
    Datta, Debika
    Chaudhary, Nitin
    FEBS LETTERS, 2020, 594 (17) : 2894 - 2903
  • [6] An investigation into the role of turn-supporting motif in polyglutamine binding peptide (QBP1) in Huntingtin aggregation inhibition
    Belwal, V. K.
    Datta, D.
    Chaudhary, N.
    FEBS OPEN BIO, 2021, 11 : 176 - 176
  • [7] Prevention of polyglutamine oligomerization and neurodegeneration by the peptide inhibitor QBP1 in Drosophila
    Nagai, Y
    Fujikake, N
    Ohno, K
    Higashiyama, H
    Popiel, HA
    Rahadian, J
    Yamaguchi, M
    Strittmatter, WJ
    Burke, JR
    Toda, T
    HUMAN MOLECULAR GENETICS, 2003, 12 (11) : 1253 - 1259
  • [8] Optimization of a polyglutamine aggregation inhibitor peptide (QBP1) using a thioflavin T fluorescence assay
    Hamuro, Lora
    Zhang, Guangtao
    Tucker, Timothy J.
    Self, Christopher
    Strittmatter, Warren J.
    Burke, James R.
    ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2007, 5 (05) : 629 - 636
  • [9] Identification of QBP1, a synthetic peptide that preferentially binds expanded polyglutamine domain by phage display technique.
    Nagai, Y
    Tucker, TJ
    Kenan, DJ
    Henderson, BS
    Keene, JD
    Strittmatter, WJ
    Burke, JR
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A463 - A463
  • [10] Protein transduction domain-mediated delivery of QBP1 suppresses polyglutamine-induced neurodegeneration in vivo
    Popiel, H. Akiko
    Nagai, Yoshitaka
    Fujikake, Nobuhiro
    Toda, Tatsushi
    MOLECULAR THERAPY, 2007, 15 (02) : 303 - 309
12345